Novo to Begin New Trial of Combo Weight-Loss Drug

Published on December 20, 2024

Novo Nordisk said on Friday it will begin a new trial of its experimental next-generation CagriSema drug in the first half of 2025 that it hopes will show greater weight-loss, after posting disappointing late-stage trial data. “We plan to optimize dose titration to further…

Read Full Article (External Site)